10:47 EST 10th December 2018 | BioPortfolio

AMSON respects the privacy of visitors to our web site, and we recognize your need for appropriate protection and management of the personally identifiable information you share with us, such as your name, address, e-mail address, and telephone number. You may visit our web site without telling us anything about yourself. If you contact us and choose to provide personally identifiable information, we will utilize it to respond to your inquiry. We do not collect or maintain personally identifiable information for resale purposes, or share your information with any other company or organization.


55-A, Mayo Road, Civil Lines,


Phone: (92-51) 5581067, 5584551
Fax: (92-51) 5586291-2

News Articles [956 Associated News Articles listed on BioPortfolio]

Pfizer puts up $425M in flu vaccines deal

A new research collaboration between the big pharma and Germany's BioNTech focuses on creating mRNA-based vaccines for preventing influenza.

Sementis and Enesi Pharma partner to develop needle-free vaccines

Australian biotechnology firm Sementis has entered into a research and development (R&D) partnership with UK-based Enesi Pharma for the development...Read More... The post Sementis and Enesi Pharm...

With BioNTech Deal, Pfizer Becomes Latest to Bet on mRNA Vaccines

Pfizer has become the latest drug maker to bet that synthetic messenger RNA molecules (mRNA) can be a new source for vaccines. This morning, the New York pharma company cut a deal with BioNTech, of Ge...

Do Vaccines Cause Autism and Other Health Problems?

(Vox) – The scientific evidence is very clear: There’s no link between vaccines and autism, and vaccines are generally safe, although they can cause some rare, typically minor side effects. In...

Here's Five Vaccines to Keep Your Eye on

On a dollar-for-dollar basis, vaccines have probably had a greater positive effect on global health than any other medical advancement, except possibly antibiotics. Yet as a whole, it’s an area that...

Pfizer, BioNTech to develop mRNA-based vaccines for influenza

Under the deal, the partnership will carry out research and development activities for the advancement of mRNA-based flu vaccines. BioNTech co-founder and CEO Dr Ugur Sahin said: “Today’s The pos...

Why Are Vaccines So Important?

(Vox) – Since vaccines were first developed in the late 18th century, they have been used to combat and even eradicate many deadly illnesses. And despite some concerns from skeptics, vaccines ha...

Despite Being Considered Low Margin, Companies Still Go After Vaccines

The biopharma industry generally views vaccines to be low-margin investments. From a public health perspective, however, vaccines can be one of the best investment dollars.

Drugs and Medications [247 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [501 Associated PubMed Articles listed on BioPortfolio]

Comparative effectiveness of H7N9 vaccines in healthy individuals.

Avian H7N9 influenza viruses possess a potential pandemic threat to public health worldwide, and have caused severe infection and high mortality in humans. A series of clinical trials of H7N9 vaccines...

as a Vector for Cancer Immunotherapy: Current Understanding and Progress.

, a Gram-positive facultative anaerobic bacterium, is becoming a popular vector for cancer immunotherapy. Indeed, multiple vaccines have been developed utilizing modified as a tool for generating imm...

Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines.

Vaccination with conjugated meningococcal vaccines is the best way to prevent invasive meningococcal disease. Changes in serogroup epidemiology have led to the inclusion of quadrivalent vaccines in th...

Vaccination with a DNA vaccine encoding CD317-targeting HBs antigen elicits enhanced immunity in mice.

Conventional hepatitis B virus (HBV) vaccines fail to induce protective antibody titers in 5-10% of immune-competent vaccines. Therefore, safe and effective HBV vaccines are still clinically needed.

Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist Perspective.

Vaccination against influenza is the most effective approach for reducing influenza morbidity and mortality. However, influenza vaccines are unique among all licensed vaccines as they are updated and ...

Clinical Trials [1113 Associated Clinical Trials listed on BioPortfolio]

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Study to Test the Safety of Three Experimental HIV Vaccines

The purpose of this study is to test three experimental HIV vaccines. This study will look at whether it is safe to give these vaccines together and how the immune system responds to the ...

Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers

Study to assess the ability of healthy subjects to build anitbodies to tetanus and pneumococcal vaccines after receiving a single intravenous dose of Abatacept, a drug which is being devel...

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants

The purpose of this study is to compare the body's immune response when vaccines are given alone versus when vaccines are given along with the study drug called ixekizumab. The vaccines p...

Companies [1140 Associated Companies listed on BioPortfolio]


AMSON respects the privacy of visitors to our web site, and we recognize your need for appropriate protection and management of the personally identifiable information you share with us, such as your ...

Novartis Vaccines and Diagnostics

Novartis Vaccines is a global leader in providing vaccines to protect against deadly meningococcal disease. Through industry-leading scientific expertise, the company is focused on extending critical ...

Glide Pharma

Glide Pharma is a specialty pharmaceutical company focused on the easy, safe and convenient administration of solid dose formulations of therapeutics and vaccines. The company has a range of in-ho...

Glide Pharmaceutical Technologies Ltd

Based near Oxford, UK, Glide Pharma is developing a pipeline of Glide-branded, “supergeneric” products and is also co-developing products with a growing list of pharmaceutical and biotech partners...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

More Information about "AMSON VACCINES & PHARMA (PVT) LTD I" on BioPortfolio

We have published hundreds of AMSON VACCINES & PHARMA (PVT) LTD I news stories on BioPortfolio along with dozens of AMSON VACCINES & PHARMA (PVT) LTD I Clinical Trials and PubMed Articles about AMSON VACCINES & PHARMA (PVT) LTD I for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AMSON VACCINES & PHARMA (PVT) LTD I Companies in our database. You can also find out about relevant AMSON VACCINES & PHARMA (PVT) LTD I Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record